Bullish Stocks: GTT Communications (NYSEMKT:GTT), MEI Pharma (NASDAQ:MEIP), Inovio Pharmaceuticals Inc. (NYSEMKT:INO), CONN’S (NASDAQ:CONN)



On March 18, 2014, GTT Communications, Inc. (NYSEMKT:GTT) issued a press release relating to the fourth quarter and year ended December 31, 2013 financial results. GTT Communications Inc. (NYSEMKT:GTT) stock performance was 11.86% in last session and finished the day at $10.85. Traded volume was 120,166.00 shares in the last session and the average volume of the stock remained 112,980.00 shares. The beta of the stock remained 0.96.

On March 21, 2014, the Board of Directors of MEI Pharma, Inc. (NASDAQ:MEIP) amended and restated the Company’s by-laws. MEI Pharma Inc. (NASDAQ:MEIP) rose 12.10% to $11.21 yesterday on volume of 468,904.00 shares. The intra-day range of the stock was $9.95 – $11.45. MEI Pharma Inc. (NASDAQ:MEIP) has a market capitalization of 224.95 million.

Inovio Pharmaceuticals (NYSE:INO) saw a significant growth in short interest in January. As of March 14th, there was short interest totalling 24,207,003 shares, a growth of 6.3% from the February 28th total of 22,762,993 shares, Analyst Ratings Network reports. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock on March 27, 2014 reported a higher of 12.69% to the closing price of $3.64. Its fifty two weeks range is $0.49 – $3.95. The total market capitalization recorded 760.23 million. The overall volume in the last trading session was 17.44 million shares. In its share capital, Inovio Pharmaceuticals Inc. (NYSEMKT:INO) has 208.86 million outstanding shares.

Conn’s (NASDAQ:CONN) shares popped Thursday after the retailer and credit provider said credit portfolio performance has started to improve. On Thursday, shares of CONN’S, Inc. (NASDAQ:CONN) advanced 13.04% to close the day at $39.02. Company return on investment (ROI) is 9.00% and its monthly performance is recorded as 8.45%. CONN’S, Inc. (NASDAQ:CONN) quarterly revenue growth is -50.29%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone